Walter E. DeWolf

59 papers receiving 2.8k citations

Walter E. DeWolf's Hit Papers

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors 2017 · 363 citations
3630+3+6Years since publication100200300

Peers

Walter E. DeWolf
Comparison fields: 5 of 108
  • Biochemistry 196
  • Organic Chemistry 650
  • Cancer Research 250
  • Molecular Medicine 109
  • Computational Theory and Mathematics 254
Replace Zhihua Sui with:
Zhihua Sui United States
W. Todd Lowther United States
Jules A. Shafer United States
Wenfang Xu China
Joseph G. Cory United States
Fredrik Björkling Denmark
Daniel A. Bachovchin United States
Jacopo Sgrignani Italy
Xianzhang Bu China
Fabrizio Carta Italy
Walter E. DeWolf relative to Zhihua Sui United States Zhihua Sui's profile →
Citations per field
00.5×2×4×6.3×
Zhihua Sui · 1×
Citations per year

Countries citing papers authored by Walter E. DeWolf

Since Specialization
Citations

This map shows the geographic impact of Walter E. DeWolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. DeWolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. DeWolf more than expected).

Fields of papers citing papers by Walter E. DeWolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter E. DeWolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. DeWolf. The network helps show where Walter E. DeWolf may publish in the future.

Co-authors

The 25 scholars most cited alongside Walter E. DeWolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Walter E. DeWolf Line = papers co-authored together Walter E. DeWolf links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors
Hit paper breakdown →
2017363
2 2000214
3 2002155
4 2001150
5 2003148
6 1998136
7 2001116
8 2001112
9 2002103
10 2003103
11 199995
12 200285
13 200081
14 198862
15 198757
16 200157
17
ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models.
200953
18 198852
19 198648
20 197947

About Walter E. DeWolf

Walter E. DeWolf is a scholar working on Pharmacology, Organic Chemistry, Biochemistry, Molecular Biology and Inorganic Chemistry, having authored 59 papers that have together received 3k indexed citations. Recurring topics across this work include Synthesis and biological activity (12 papers), Enzyme function and inhibition (8 papers), Pancreatic function and diabetes (7 papers), Diabetes Treatment and Management (7 papers), Cell death mechanisms and regulation (7 papers), Metal-Catalyzed Oxygenation Mechanisms (7 papers), Microbial Natural Products and Biosynthesis (6 papers) and Synthesis and Biological Evaluation (6 papers). The work is most often cited by research in Biochemistry (196 citations), Organic Chemistry (650 citations), Cancer Research (250 citations), Molecular Medicine (109 citations) and Computational Theory and Mathematics (254 citations). Walter E. DeWolf has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Lawrence I. Kruse, Paul Malcolm Keller, Paula J. Goodhart, Dennis M. Lee, David J Payne, MARK E. NUTTALL, Terrance D. Moore, Stephen F. Rittenhouse, Vern L. Schramm and William F. Huffman. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact